Contract Manufacturing

CPhI shifts from real-world to digital realm

16-Sep-2020 By Jenni Spinner

In the face of the COVID-19 pandemic, CPhI Festival of Pharma organizers have shifted the event online but kept the industry content.

Seqens launches HPAPI manufacturing at 100-year-old site

14-Sep-2020 By Jenni Spinner

The global pharmaceutical ingredient producer has opened a high-potency active pharmaceutical ingredient unit at its century-old facility in France.

Ajinomoto grows small-molecule capabilities in India

18-Aug-2020 By Jenni Spinner

The CDMO is expanding its small-molecule manufacturing capacity with a new 8,500-square-meter production facility at its Visakhapatnam, India site.

Grand River Aseptic Manufacturing tackles unique expansion

11-Aug-2020 By Jenni Spinner

When growing market demand moved the Michigan CDMO to expand, it opted for a novel design-construction approach to building bigger digs.

ACD/Labs: tech can overcome supply chain challenges

06-Aug-2020 By Jenni Spinner

A leader from the scientific software provider discusses the most challenging obstacles in the pharma supply chain, and solutions that can conquer them.

People on the Move: August 2020

04-Aug-2020 By Jenni Spinner

This month's spotlight on new hires, promotions and company acquisitions involves Elligo Health Research, PPD, Pfizer, Covance and other industry firms.

Indegene: e-labeling could make paper inserts obsolete

28-Jul-2020 By Jenni Spinner

A leader from the life-sciences solutions firm explains how electronic drug labels and inserts offer widespread benefits to various stakeholders.

FHI Clinical to support ACTT remdesivir trial for COVID-19

23-Jul-2020 By Jenni Spinner

The CRO has been tapped by the Frederick National Laboratory for Cancer Research to provide clinical services for an ongoing COVID-19 study

Quartic.ai, Sparta Systems partner on ‘smart’ manufacturing tech

14-Jul-2020 By Jenni Spinner

The two companies are collaborating on AI-enabled risk detection, intended to increase pharma product quality and process efficiency.

Sandoz, Civica RX partner to stem shortage of generics

09-Jul-2020 By Jenni Spinner

The two companies plan to join forces in order to help healthcare providers anticipate and avoid shortages of critical injectable generic medications.

ChargePoint butterfly valve safely handles APIs

29-Jun-2020 By Jenni Spinner

The company’s PharmaSafe containment split butterfly valve is designed for safe handling of non-sterile API and formulation ingredients.

Colorcon launches drug authentication platform

29-Jun-2020 By Jenni Spinner

The company’s SoteriaRx platform offers on-dose technology and detection services for authenticating a broad range of medications.

HPAPI Summit tackles trends and technology

24-Jun-2020 By Jenni Spinner

The ninth annual event, taking place in Boston mid-November, will feature industry professionals addressing manufacturing practices, regulatory updates and market trends.

Evonik launches Resomer Precise custom functional excipients

15-Jun-2020 By Jenni Spinner

The company reportedly is harnessing sophisticated technology to enable process validation of polymers to tight specifications in parenteral drugs.

Rho: evolution of drug development reflects focus on quality

29-May-2020 By Jenni Spinner

A representative of the research and development firm offers perspective on how the industry has shifted in recent years, thanks to a number of forces.

Sterling Pharma kicks off hydroxychloroquine production

19-May-2020 By Jenni Spinner

The British CDMO will manufacture the API for the potential COVID-19 treatment, and partner Accord Healthcare will manufacture the finished product.

Gilead, Cipla partner on remdesivir expansion

14-May-2020 By Jenni Spinner

The two companies will join forces on wider manufacturing and distribution of the investigational drug, granted an EUA to treat COVID-19 patients.

Nanoform granted GMP certification

14-May-2020 By Jenni Spinner

The Finnish nanoparticle technology specialist’s facility has been given the stamp of approval by the Finnish Medicines Agency.

Romaco Kilian unveils high-speed tablet press

12-May-2020 By Jenni Spinner

The double-sided S 710 Prime rotary press is designed for compressing single- and dual-layer tablets, promising high productivity.

Quartic.ai, Bright Path Labs to partner on AI-powered API manufacturing

11-May-2020 By Jenni Spinner

The two firms are joining forces to develop AI-based technology for continuous manufacturing of critical APIs necessary for producing crucial small-molecule drugs.

People on the Move: May 2020

06-May-2020 By Jenni Spinner

This month’s new hires and promotions include executive appointments at Advarra, Eversana, Signant Health, Endpoint Clinical and other companies.

I Holland: beating COVID-19 obstacles is crucial

09-Apr-2020 By Jenni Spinner

The pharmaceutical supplier says companies need to do everything in their power to keep the supply chain moving smoothly in the face of COVID-19.

MedPharm donates hand sanitizer to combat COVID-19

31-Mar-2020 By Jenni Spinner

The company has shifted production to manufacture sanitizer, intended to protect healthcare providers and other essential workers from coronavirus.

Developer seeks collaborators to advance potential coronavirus treatment

30-Mar-2020 By Vassia Barba

Bold is on the hunt for supporters among the industry to help evaluate its investigational anti-cancer therapy as a potential coronavirus treatment, after seeing related elements.

Thermo Fisher to invest $475m into biopharma in 2020

25-Mar-2020 By Ben Hargreaves

Continuing a trend among larger CDMOs, Thermo Fisher reveals scale of investment into biopharma business and further focus on cell and gene therapy.

ProBioGen, Immunogenesis in cell line development agreement

24-Mar-2020 By Vassia Barba

Immunogenesis is tapping into ProBioGen’s manufacturing capabilities for its immuno-oncology lead candidate, as the potential treatment enters the clinic.

Pharma events update: rescheduled, canceled, online

18-Mar-2020 By Jenni Spinner

This list includes the industry events that have been postponed or moved because of the coronavirus pandemic.

Fujifilm Diosynth to create biocampus in the UK

18-Mar-2020 By Vassia Barba

Fujifilm Diosynth announced plans to build a research center in the UK to answer growing demand in services for biologics, vaccines, and gene therapies development.

AR company offers coronavirus-safe collaboration kits

17-Mar-2020 By Jenni Spinner

Apprentice is sending sets of technology tools to pharmaceutical research and manufacturing facilities, including its Tandem AR collaboration platform.

Altasciences acquires Alliance Contract Pharma

12-Mar-2020 By Jenni Spinner

The contract research organization has purchased Alliance Contract Pharma, a small-molecule contract manufacturing and analytical firm.

Formulation method improves bioavailability of poorly soluble molecules

09-Mar-2020 By Vassia Barba

Orion to benefit from Nanoform’s formulation technology, which is able to improve bioavailability and solubility of early-stage compounds.

WuXi in deal to develop Vir’s antibody against coronavirus

27-Feb-2020 By Vassia Barba

Vir Biotechnology turns to WuXi to support development and commercialization of an antibody-based potential treatment for the coronavirus.

Frontage continues build-out to meet late-stage developers demand

27-Feb-2020 By Vassia Barba

Frontage has announced completion of its Pennsylvania site expansion to boost its offering of bioanalytical services for late-stage cell and gene therapies developers.

BIA Separations in deal to expand virus purification offering

20-Feb-2020 By Vassia Barba

In its latest deal, BIA Separations brings to market an elution method developed by the University of Zagreb, which helps preserve viruses’ integrity, infectivity, and potency.

LakePharma and NJ Bio partner on ‘one-stop’ ADC manufacturing service

19-Feb-2020 By Vassia Barba

Antibody-focused service providers merge their offerings to create a ‘seamless workflow’ on antibody-drug conjugates to help save developers’ time and costs.

Univercells expands its offering to meet ‘fast-growing’ gene therapy demand

19-Feb-2020 By Vassia Barba

Funding from Gamma supports the development of Univercells’ biomanufacturing platform and bioreactors, with the latter looking to expand into the fast-growing gene therapy segment.

GSK's pullback from low-margin contract manufacturing drags on results

10-Feb-2020 By Nick Taylor

GSK blames retreat from low-margin contract manufacturing for flat fourth quarter performance of consumer health unit.

Vetter consolidates development labs in one location

04-Feb-2020 By Ben Hargreaves

Vetter decides to house its development laboratories together in Ravensburg, Germany, to modernize capabilities, with plans for further expansion.

Pfizer's CDMO unit drives growth at hospital business

03-Feb-2020 By Nick Taylor

Pfizer attributes performance of contract manufacturing unit as driver of growth at hospital business.

Bellicum offloads cell therapy plant in switch to outsourced production

28-Jan-2020 By Nick Taylor

Bellicum sells cell therapy manufacturing plant to MD Anderson Cancer Center, strikes master service agreement.

New CDMO plans $1.1bn cell and gene therapy plant

27-Jan-2020 By Nick Taylor

A newly founded CDMO has outlined plans to invest $1.1bn to become the world’s biggest cell and gene therapy service provider.

Merck looks to CMOs to help ease vaccine supply bottleneck

20-Jan-2020 By Nick Taylor

Merck enlists CMOs to help increase Gardasil manufacturing capacity in response to rising demand.

Surging local demand drives 24% growth of Korean contract service sector

15-Jan-2020 By Nick Taylor

South Korean contract service market grows 24% as local biopharma companies step up spending.

Yposkesi doubles manufacturing footprint to meet AAVs growing demand

14-Jan-2020 By Vassia Barba

Yposkesi CDMO announces expansion to cover growing demand, strikes a deal on viral vectors production for a gene therapy development project.

FDA places Innate cancer trial on partial clinical hold over CMO issue

14-Jan-2020 By Nick Taylor

The US FDA puts Innate Pharma trial on partial clinical hold after learning of CMO problems.

WuXi Biologics and Almirall partner to develop dermatological treatments

09-Jan-2020 By Vassia Barba

Almirall enters drug discovery agreement with WuXi Biologics, gaining access to the WuXiBody platform to develop antibodies for the treatment of dermatological diseases.

CMO problems prompt Innate to put trial on partial hold

24-Dec-2019 By Nick Taylor

Innate Pharma stops dosing new patients in clinical trial amid problems at manufacturing partner.

3M set to sell biopharma-focused CDMO for $650m

23-Dec-2019 By Nick Taylor

3M agrees to sell drug delivery contract service unit to investment group Altaris Capital Partners.

Avid frames Halozyme setback as potential positive for CDMO business

19-Dec-2019 By Nick Taylor

Avid Bioservices sees potential upside to clinical development setback at big customer Halozyme.

Sanofi to 'optimize' CMOs to drive down spending

18-Dec-2019 By Nick Taylor

Sanofi plans “optimization of CMOs and suppliers” as new CEO targets €2bn in savings by 2022.

Product Innovations

Generic method approach for determination of residual solvents in active pharmaceutical ingredients by gas chromatography

Solvents are defined as organic chemicals that are used to dissolve components. They are used during the manufacture of drug substances and can also potentially...

Pulmonary Delivery of Orally Inhaled Therapeutics

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...

Addressing Challenges with Clinical In-Use Testing

Lonza Drug Product expert Léa Sorret PhD explores Clinical In-Use Testing of Biotherapeutics in this white paper. Léa shares her expertise and describes...

Outsourcing-Pharma

Resources